Target intelligence / Profile preview

Lipofuscin

Molecular classification: Intracellular aging pigment, Heterogeneous intracellular pigment composed of nondegradable aggregates of lipids, proteins, carbohydrates, and metal ions, Main fluorescent component: A2E (N-retinylidene-N-retinylethanolamine), a pyridinium bis-retinoid

Overview

Lipofuscin is an intracellular aging pigment composed of nondegradable aggregates of oxidized lipids and proteins that progressively accumulate within retinal pigment epithelium cells throughout life. The pigment forms through incomplete lysosomal degradation of material from phagocytosed photoreceptor outer segments and autophagy of damaged organelles, with oxidative modification playing a central role in its genesis. While A2E (a pyridinium bis-retinoid derivative of vitamin A) is the most studied fluorescent component, it represents only part of lipofuscin's complex composition. Lipofuscin is notably photoreactive to short-wavelength visible light, generating reactive oxygen species and causing oxidative damage to RPE cells, and its accumulation correlates with age-related macular degeneration. The pigment is clinically significant as the main fluorophore visualized in fundus autofluorescence imaging, making it useful for diagnosing and monitoring retinal degenerative diseases. However, lipofuscin itself is not a therapeutic target but rather a pathological consequence of aging and oxidative stress in the retina.

Other names: age pigmentage-related pigment

Mechanism of action

Not applicable, as Lipofuscin is not a therapeutic target, and no drugs currently exist to directly target its formation or clearance.

Biological functions

Accumulates with age in RPE cells, reaching peak levels around age 70 and potentially occupying up to one-third of RPE cytoplasmic space in aged individualsForms through incomplete lysosomal degradation of phagocytosed photoreceptor outer segments, creating lipofuscin precursorsForms through autophagy, involving the degradation of intracellular organelles such as mitochondriaFormation is significantly influenced by oxidative modification due to the high susceptibility of the photoreceptor/RPE complex to oxidative stress (sunlight exposure, elevated oxygen, high polyunsaturated fatty acid content)

Disease associations

Accumulation in RPE cells correlates with the development of Age-Related Macular Degeneration (AMD)Contributes to oxidative stress and RPE cell dysfunction in AMD due to its photoreactivity, generating reactive oxygen species (ROS) including singlet oxygen, superoxide anion, and hydrogen peroxidePhotoreactive to short-wavelength visible light (390-550 nm), causing lipid peroxidation, protein oxidation, loss of lysosomal integrity, and ultimately cell deathAccumulation and oxidative effects may initiate a pathogenic cascade leading to Drusen formation and RPE cell lossUnclear whether it is a causative agent of retinal degenerative disease or a consequence of it

Safety considerations

The complete biochemical composition of lipofuscin remains mostly unknown, hindering full understanding of its propertiesThe relative contributions of different lipofuscin components (e.g., A2E vs. other fluorophores and insoluble fraction) to pathogenesis are unclearIt remains an open question whether lipofuscin is a causative agent or merely a consequence in retinal degenerationEffective strategies to prevent lipofuscin formation or promote its clearance have not been established

Biomarkers

Fundus Autofluorescence (FAF): Lipofuscin demonstrates characteristic orange-red or golden-yellow autofluorescence when excited with ultraviolet or blue lightClinically exploited in fundus autofluorescence imaging to visualize and monitor retinal disease progressionLipofuscin granules show peak emission at 600 nm when excited at 364 nm or 476 nm (excitation employed by in vivo autofluorescence systems)

Beyond the preview

Go deeper on Lipofuscin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipofuscin.

Explore the full profile